Search results for "Cancer screening"

showing 10 items of 73 documents

Coronary artery calcium score on low-dose computed tomography for lung cancer screening

2013

Aim: To evaluate the feasibility of coronary artery calcium score (CACS) on low-dose non-gated chest CT (ngCCT). Methods: Sixty consecutive individuals (30 males; 73 ± 7 years) scheduled for risk stratification by means of unenhanced ECG-triggered cardiac computed tomography (gCCT) underwent additional unenhanced ngCCT. All CT scans were performed on a 64-slice CT scanner (Somatom Sensation 64 Cardiac, Siemens, Germany). CACS was calculated using conventional methods/scores (Volume, Mass, Agatston) as previously described in literature. The CACS value obtained were compared. The Mayo Clinic classification was used to stratify cardiovascular risk based on Agatston CACS. Differences and corre…

High-resolution computed tomographymedicine.medical_specialtyCoronary artery calcium scoreunenhanced chest computed tomographymedicine.diagnostic_testbusiness.industryCoronary artery calcium scorecardiovascular risk stratificationLow dosenutritional and metabolic diseasesComputed tomographyLower riskEffective dose (radiation)SurgeryLung cancer screeningcardiovascular systemmedicineProspective Studycardiovascular diseasesSettore MED/36 - Diagnostica Per Immagini E RadioterapiaAgatston scoreNuclear medicinebusinessHigh-resolution computed tomographyLung cancer screeningWorld Journal of Radiology
researchProduct

Cell-Free Circulating Plasma hTERT mRNA Is a Useful Marker for Prostate Cancer Diagnosis and Is Associated with Poor Prognosis Tumor Characteristics

2012

BackgroundSerum prostate-specific antigen (PSA) is the most widely used marker for diagnosing prostate cancer (PCa). It lacks specificity and predictive value, resulting in inaccurate diagnoses and overtreatment of the disease. The aim of this study was to assess the usefulness of plasma telomerase reverse transcriptase (hTERT) mRNA as a diagnostic and prognostic tool for PCa and its association with clinicopathological parameters of tumors.Principal findingsPlasma hTERT mRNA levels were determined by qRT-PCR in 105 consecutive patients with elevated PSA levels and in 68 healthy volunteers. The diagnostic accuracy, the efficacy as a prognostic factor of biochemical recurrence and the associ…

MaleBiochemical recurrenceOncologymedicine.medical_specialtyPathologyUrologyScienceProstate cancerDiagnostic MedicineInternal medicineBlood plasmaBiopsyBiomarkers TumorPathologyCancer Detection and DiagnosisEarly DetectionHumansMedicineTelomerase reverse transcriptaseRNA MessengerTelomeraseAgedBenign Prostatic HyperplasiaTumor markerAged 80 and overClinical ChemistryUnivariate analysisMultidisciplinarymedicine.diagnostic_testbusiness.industryProstate CancerQProstate DiseasesRProstatic NeoplasmsMiddle AgedPrognosismedicine.diseaseClinical Laboratory SciencesOncologyMedicineBiomarker (medicine)businessBiomarkersCancer ScreeningResearch ArticleGeneral PathologyPLoS ONE
researchProduct

Trends in net survival from liver cancer in six European Latin countries: results from the SUDCAN population-based study

2016

Liver cancer represents a major clinical challenge. The aim of the SUDCAN collaborative study was to compare the net survival from liver cancer between six European Latin countries (Belgium, France, Italy, Portugal, Spain and Switzerland) and provide trends in net survival and dynamics of excess mortality rates (EMRs) up to 5 years after diagnosis. The data were extracted from the EUROCARE-5 database. First, net survival was studied over the period 2000-2004 using the Pohar-Perme estimator. For trend analyses, the study period was specific to each country. Results are reported from 1992 to 2004 in France, Italy, Spain and Switzerland and from 2000 to 2004 in Belgium and Portugal. These tren…

MaleCancer ResearchDatabases FactualEpidemiologyTrends in survival0302 clinical medicineBelgiumCancer screeningMedicineCancer registries030212 general & internal medicineRegistriesYoung adultAged 80 and overmedicine.diagnostic_testMortality rateMedical recordLiver NeoplasmsMiddle Aged3. Good healthCancer registries; Europe; Excess mortality rate; Liver cancer; Net survival; Trends in survival;Survival RateEuropeOncologyItaly030220 oncology & carcinogenesisPopulation SurveillanceFemaleFranceLiver cancerLiver cancerSwitzerlandAdultAdolescentSocio-culturale03 medical and health sciencesYoung AdultNet survivalHumansAgedPortugalExcess mortality ratebusiness.industryPublic Health Environmental and Occupational Healthmedicine.diseaseCancer registrySpainLiver functionbusinessLiver function testsDemography
researchProduct

Influence of sample return time and ambient temperature on the performance of an immunochemical faecal occult blood test with a new buffer for colore…

2016

IF 2.415; International audience; The haemoglobin concentration measured by faecal immunochemical tests (FIT) may be decreased in cases of delayed sample return or high temperature. It is an issue of great importance. The aim of this study was to investigate the effects of sample return time and of season on the performance of an FIT (FOB-Gold) with a new buffer. The study included 20 371 participants involved in the French organized colorectal cancer (CRC) screening programme. The probability of a positive screening test, detection rates and positive predictive values for CRC and advanced adenoma were analysed according to sample return time and season of screening. A sample of positive FI…

MaleCancer ResearchMultivariate analysisTime FactorsEpidemiologyColorectal cancerMESH: Reagent Kits DiagnosticMESH : AgedMESH : HemoglobinsMESH : Early Detection of Cancer[ SDV.CAN ] Life Sciences [q-bio]/CancerReturn timeScreening programmeImmunoenzyme TechniquesHemoglobinsMESH : Specimen HandlingMESH : FemaleMESH : Neoplasm StagingMESH : Reagent Kits DiagnosticMESH : TemperatureEarly Detection of CancerMESH: AgedMESH: Middle AgedMESH : PrognosisTemperatureMESH: Follow-Up StudiesMESH: Neoplasm StagingMiddle AgedPrognosisPredictive valueMESH: TemperatureMESH: HemoglobinsMESH : Occult BloodOncologyColorectal cancer screeningOccult BloodFemaleSeasonsMESH : Colorectal NeoplasmsColorectal NeoplasmsMESH : Time FactorsAdenomamedicine.medical_specialtySample (material)MESH : Male[SDV.CAN]Life Sciences [q-bio]/CancerMESH: PrognosisSpecimen HandlingAnimal scienceMESH : Immunoenzyme TechniquesmedicineHumansMESH: Early Detection of CancerMESH : Middle AgedMESH: Specimen HandlingMESH: Immunoenzyme TechniquesAgedNeoplasm StagingMESH: AdenomaMESH: HumansMESH : Seasonsbusiness.industryMESH: Time FactorsMESH : HumansPublic Health Environmental and Occupational HealthMESH : Follow-Up Studiesmedicine.diseaseMESH: MaleSurgeryMESH : AdenomaReagent Kits DiagnosticFaecal occult blood testbusinessMESH: Occult BloodMESH: FemaleMESH: SeasonsMESH: Colorectal NeoplasmsFollow-Up Studies
researchProduct

Impact of screening programme using the faecal immunochemical test on stage of colorectal cancer: Results from the IMPATTO study

2019

To evaluate the impact of faecal immunochemical test (FIT) screening on stage distribution at diagnosis, and to estimate relative incidence rates by stage in screened at first and subsequent rounds vs. unscreened. We included all incident cases occurring in 2000-2008 in 50- to 71-year-olds residing in areas with an FIT-screening programme. Multinomial logistic models were computed to estimate the relative risk ratio (RRR) of stages I and IV, compared to stage II + III, adjusting for age, sex, geographical area, and incidence year. Proportions were then used to estimate incidence rate ratios (IRR) by stage for screened subjects at the first and at subsequent rounds vs. unscreened subjects, a…

MaleCancer Researchmedicine.medical_specialtyColorectal cancerPrevalenceSocio-culturaleColonoscopyColorectal NeoplasmSettore MED/42 - Igiene Generale E Applicatacolorectal cancer screeningScreening programmeFeces03 medical and health sciences0302 clinical medicinecolonoscopyFaecal immunochemical test colonoscopy colorectal cancer screening epidemiology cancer registriesInternal medicineEpidemiologymedicineHumansStage (cooking)Early Detection of CancerAgedNeoplasm StagingProportional Hazards Modelscancer registriemedicine.diagnostic_testFaecal immunochemical testbusiness.industryIncidence (epidemiology)IncidenceMiddle Agedmedicine.diseaseImmunohistochemistryOncologyItalycancer registries030220 oncology & carcinogenesisRelative riskOccult BloodepidemiologyFeceFemaleNeoplasm GradingColorectal NeoplasmsbusinessHuman
researchProduct

Professionals’ role in implementing a cervical cancer screening program

2014

The objectives of this study were to investigate the awareness, motivation, and readiness of medical staff to take part in a cervi cal cancer screening program (CSP), with the ultimate aim of increasing the response rate to invitation letters and improving CSP effectiveness and coverage. Certified gynecologists (GYNs) and general practitioners (GPs) practicing in the national and private healthcare systems in Latvia were given specially designed multiple-choice questionnaires. Of 213 questionnaires distributed to GYNs, 74% were completed (32% response rate of all 486 GYNs in Latvia). GPs were sent 933 questionnaires, 24% were returned (15% response rate of all 1,455 GPs in Latvia). GPs regi…

MaleHealth Knowledge Attitudes Practicemedicine.medical_specialtyMedical staffeducationUterine Cervical NeoplasmsDermatologyCervical cancer screeningNursingGeneral PractitionersSurveys and QuestionnairesCancer screeningmedicineHumansMass ScreeningPhysician's RoleCervical cancerResponse rate (survey)business.industryMiddle Agedmedicine.diseaseLatviaInfectious DiseasesGynecologyFamily medicineCervical cancer preventionFemalePrivate healthcarebusinessActa Dermatovenerologica Alpina Pannonica et Adriatica
researchProduct

A smart tele-cytology point-of-care platform for oral cancer screening.

2019

Early detection of oral cancer necessitates a minimally invasive, tissue-specific diagnostic tool that facilitates screening/surveillance. Brush biopsy, though minimally invasive, demands skilled cyto-pathologist expertise. In this study, we explored the clinical utility/efficacy of a tele-cytology system in combination with Artificial Neural Network (ANN) based risk-stratification model for early detection of oral potentially malignant (OPML)/malignant lesion. A portable, automated tablet-based tele-cytology platform capable of digitization of cytology slides was evaluated for its efficacy in the detection of OPML/malignant lesions (n = 82) in comparison with conventional cytology and hist…

MaleMedical DoctorsHealth Care ProvidersPathology and Laboratory Medicine030218 nuclear medicine & medical imaging0302 clinical medicineCohen's kappaConventional cytologyCytologyImage Processing Computer-AssistedMedicine and Health SciencesMedical PersonnelEarly Detection of CancerMultidisciplinaryOral cancer screeningQRMiddle AgedTelemedicine3. Good healthProfessionsOncology030220 oncology & carcinogenesisMedicineFemaleMouth NeoplasmsRadiologyAnatomyRisk assessmentAlgorithmsResearch ArticleComputer and Information SciencesDysplasiamedicine.medical_specialtyHistologyCytodiagnosisPoint-of-Care SystemsRemote diagnosisScienceEarly detectionRisk AssessmentSensitivity and Specificity03 medical and health sciencesSigns and SymptomsDiagnostic MedicineArtificial IntelligenceCancer Detection and DiagnosismedicineHumansArtificial Neural NetworksPoint of careComputational Neurosciencebusiness.industryBiology and Life SciencesComputational BiologyCell BiologyPathologistsHealth CarePeople and PlacesLesionsPopulation GroupingsNeural Networks ComputerCytologybusinessNeurosciencePLoS ONE
researchProduct

Additional mailing phase for FIT after a medical offer phase: The best way to improve compliance with colorectal cancer screening in France

2017

International audience; Background: Compliance with colorectal cancer screening is critical to its effectiveness. The organisation of the mass screening programme in France has recently been modified with no evaluation of the consequences.Aims: To evaluate the impact of the way the screening test is delivered on compliance.Patients and Methods: During the first six months of the screening campaign (Ille-Vilaine, Brittany), general practitioners were asked to propose a faecal immunochemical test (FIT), OC-Sensor, to individuals at average risk for colorectal cancer (n = 152,097). A subset of non-participants in the medical phase (n = 13,071) was randomly chosen to receive a reminder that inc…

MaleMedical consultationColorectal cancer[ SDV.CAN ] Life Sciences [q-bio]/Cancer0302 clinical medicineMass ScreeningEarly Detection of Cancermedia_commonGastroenterology[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologieMiddle Aged3. Good healthTest (assessment)Colorectal cancer screeningOccult Blood030220 oncology & carcinogenesisScreening[ SDV.MHEP.HEG ] Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyFemale030211 gastroenterology & hepatologyFranceColorectal NeoplasmsCompliancemedicine.medical_specialtyReminder Systemseducation[SDV.CAN]Life Sciences [q-bio]/CancerCompliance (psychology)03 medical and health sciences[SDV.CAN] Life Sciences [q-bio]/CancermedicineHumansmedia_common.cataloged_instancePostal ServiceEuropean unionUptake rateMass screeningAgedGynecologyHepatologybusiness.industry[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyImmunochemical testmedicine.diseaseColorectal cancer[SDV.MHEP.HEG] Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieFamily medicinePatient Compliance[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiebusinessDigestive and Liver Disease
researchProduct

Informed participation in the Valencian Community Colorectal Cancer Screening Programme from a gender perspective.

2018

Abstract Objective: To examine the factors that influence informed participation in a Colorectal Cancer Screening Programme (CRCSP) from a gender perspective. Methods: Cross-sectional telephone survey directed to men and women invited to participate (2009-2010) in the Valencian Community CRCSP (Spain). Sample size: 785 subjects. Outcome variables: participation in CRCSP and being informed. Bivariate and multivariate analysis using logistic regression models (95% confidence interval [95%CI], p <0.05). Results: Being a woman (odds ratio [OR]: 1.52; 95%CI: 1.06-2.19), receiving information from a general practitioner (OR: 1.64; 95%CI: 1.05-2.55) and being informed (OR: 1.54; 95%CI: 1.08-2.21) …

MaleMultivariate analysisToma de decisión informadaGeneral PracticeLogistic regressionValencian community0302 clinical medicine030212 general & internal medicineEarly Detection of Cancerlcsh:Public aspects of medicineMiddle AgedColorectal cancer screening030220 oncology & carcinogenesisEarly detection of cancerOccult BloodFemaleInformed decision makingColorectal NeoplasmsAttitude to Healthmedicine.medical_specialtyInformation Seeking BehaviorSampling StudiesColorectal neoplasmInterviews as Topic03 medical and health sciencesSex FactorsPatient Education as TopicGender identitymedicineHumansCáncer colorrectalAgedPrimary Health Carebusiness.industryPerspective (graphical)Public Health Environmental and Occupational Healthlcsh:RA1-1270Odds ratioConfidence intervalSurgeryParticipaciónCross-Sectional StudiesDetección precoz del cáncerSocioeconomic FactorsSample size determinationFamily medicineGéneroPatient participationPatient ParticipationbusinessGaceta sanitaria
researchProduct

Need for global action for cancer control.

2008

Malemedicine.medical_specialtyCancer ResearchInternational CooperationUterine cervix cancerDiseaseGlobal HealthWorld health03 medical and health sciences0302 clinical medicineCancer controlSDG 3 - Good Health and Well-beingNeoplasmsCancer screeningmedicineGlobal healthHumans030212 general & internal medicineGynecologyHealth Services Needs and DemandCancer preventionbusiness.industryHematologyPrimary Prevention/dk/atira/pure/subjectarea/asjc/2700/2730Risk analysis (engineering)Action (philosophy)Oncology030220 oncology & carcinogenesisFemalebusiness/dk/atira/pure/subjectarea/asjc/1300/1306Annals of oncology : official journal of the European Society for Medical Oncology
researchProduct